newsfilter
← Latest News
GlobeNewswire·

Pluristem Announces End of Patient Enrollment in its Phase I Hematology Study

HAIFA, Israel, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic...